↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "db:Swepub ;mspu:(article);pers:(Lindholm B);pers:(Yenicesu M)"

Search: db:Swepub > Journal article > Lindholm B > Yenicesu M

Result 1-9 of 9

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Caglar, K, et al. (author) Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease 2008 In: Nephron. Clinical practice. - : S. Karger AG. - 1660-2110. ; 108:3, s. C233-C240 Journal article (peer-reviewed)abstract <i>Background:</i> Defective endothelial function, an initial step in the development of atherosclerotic plaque, is prevalent in moderate to advanced chronic kidney disease (CKD). In this study, the investigators hypothesized that fetuin-A, a calcification inhibitor, is a novel risk factor for the development of endothelial dysfunction in patients. <i>Methods:</i> 198 nondiabetic patients with a mean age of 44.0 ± 12.4 years and with different stages of CKD were studied. In addition to a detailed metabolic panel, flow-mediated dilatation assessed by high-resolution brachial ultrasonography was performed to determine endothelial dysfunction. Carotid intima-media thickness was also estimated by ultrasonography. Serum fetuin-A concentrations were determined by using a human ELISA method. <i>Results:</i> Endothelial dysfunction was observed in all stages (1–5) of CKD and worsened in parallel to the reduction in estimated glomerular filtration rate. Serum fetuin-A concentrations were also found to be decreased in all but stage 1 CKD. On multiple regression analysis, endothelial dysfunction was independently associated with fetuin-A (β = 0.745, p < 0.001) and intact parathyroid hormone concentrations (β = –0.216, p < 0.001). <i>Conclusion:</i> These data in a selected cohort of CKD patients indicate that fetuin-A may be one of the contributing factors for the development of endothelial dysfunction in CKD patients.
2.	Caglar, K, et al. (author) Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients 2008 In: Clinical journal of the American Society of Nephrology : CJASN. - 1555-905X. ; 3:1, s. 61-68 Journal article (peer-reviewed)
3.	Carrero, JJ, et al. (author) Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease 2012 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. - : Oxford University Press (OUP). - 1460-2385. ; 27:2, s. 709-715 Journal article (peer-reviewed)
4.	Suliman, ME, et al. (author) Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease 2008 In: Clinical journal of the American Society of Nephrology : CJASN. - 1555-905X. ; 3:4, s. 976-985 Journal article (peer-reviewed)
5.	Yilmaz, MI, et al. (author) ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction 2008 In: Journal of the American Society of Nephrology : JASN. - 1533-3450. ; 19:2, s. 388-395 Journal article (peer-reviewed)
6.	Yilmaz, MI, et al. (author) Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria 2009 In: Clinical journal of the American Society of Nephrology : CJASN. - 1555-905X. ; 4:3, s. 535-541 Journal article (peer-reviewed)
7.	Yilmaz, MI, et al. (author) Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin 2008 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. - : Oxford University Press (OUP). - 1460-2385. ; 23:5, s. 1621-1627 Journal article (peer-reviewed)
8.	Yilmaz, MI, et al. (author) Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage? 2009 In: Clinical transplantation. - : Wiley. - 1399-0012 .- 0902-0063. ; 23:2, s. 241-248 Journal article (peer-reviewed)
9.	Yilmaz, MI, et al. (author) Serum visfatin concentration and endothelial dysfunction in chronic kidney disease 2008 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. - : Oxford University Press (OUP). - 1460-2385. ; 23:3, s. 959-965 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-9 of 9

Refine your search

Type of publication: journal article (9)Undo refine

Type of content: peer-reviewed (9)

Author/Editor: Stenvinkel, P (9); Lindholm, B (9)Undo refine; Yenicesu, M (9)Undo refine; Carrero, JJ (8); Yilmaz, MI (8); Saglam, M (8); show more...; Caglar, K (7); Sonmez, A (7); Eyileten, T (7); Qureshi, AR (6); Axelsson, J (6); Oguz, Y (6); Vural, A (6); Cakir, E (5); Heimburger, O (2); Barany, P (2); Alvestrand, A (1); Suliman, ME (1); Ikizler, TA (1); Kilic, S (1); Tasar, M (1); Acikel, C (1); Ozgurtas, T (1); Yimaz, MI (1); Ipcioglu, OM (1); Tong, ML (1); Celik, T (1); Kirkpantur, A (1); Aslan, I (1); show less...

University: Karolinska Institutet (9)

Language: English (9)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view